Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-03-21

Clinical Trial Update: Treatment of High-grade Gliomas Using Hypofractionated Radiation Therapy -a Phase I Clinical Trial [NA]

View source ↗

Summary

A completed Phase I trial evaluating hypofractionated radiation therapy for high-grade gliomas to determine safety and the maximum tolerated dose.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Xue Xiaoying | Conditions: Glioma, Radiotherapy, Intensity-Modulated | NA | Status: COMPLETED